WW International Analyst Ratings
Barclays Maintains Underweight on WW International, Maintains $0.75 Price Target
Analysts Reiterate Negative Outlook on WeightWatchers (NASDAQ:WW) Stock
Barclays Maintains WW International(WW.US) With Sell Rating, Maintains Target Price $0.75
WeightWatchers (NASDAQ:WW) Stock Jumps 40% on Plan to Sell Obesity Medications
Morgan Stanley Maintains WW International(WW.US) With Hold Rating, Maintains Target Price $1.2
WW International: Strategic Shift Amid Market Challenges – A Balanced Hold Rating
Barclays Maintains WW International(WW.US) With Sell Rating, Maintains Target Price $0.75
Craig-Hallum Maintains WW International(WW.US) With Hold Rating, Announces Target Price $1
Hold Rating on WW International Amid New Semaglutide Offering and Optimistic Revenue Projections
Analyzing Risks and Margins: A Sell Rating for WW International's New Semaglutide Venture
Barclays Maintains WW International(WW.US) With Sell Rating, Maintains Target Price $0.75
Barclays Issues a Sell Rating on WW International (WW)
Craig-Hallum Maintains WW International(WW.US) With Hold Rating
Craig-Hallum Maintains WW International(WW.US) With Hold Rating
WW International (WW) Gets a Hold From Craig-Hallum
Oppenheimer Maintains WW International(WW.US) With Hold Rating
WW International Price Target Cut to $1.00/Share From $2.10 by UBS
UBS Maintains Neutral on WW International, Lowers Price Target to $1
WW International Analyst Ratings